View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Daratumumab 1800, maintenance after Dexamethasone (20/20/40) / Cyclophosphamide 300 / Daratumumab 1800 / Bortezomib 1.3 - Daratumumab 1800 maintenance, AL amyloidosis, cycle 7+
Protocol-ID: 1633 V1.0 (Mini), DEXA(20/20/40)/CYCL300/DRTM1800/BORT1,3 - DRTM1800 maint., AL amyloidosis, C7+Indication(s)
- Amyloidosis (AL Amyloidosis); ICD-10 E85.-
Links
- Daratumumab: Risiko der Reaktivierung von Hepatitis B [BfARM Risikoinf. Rote Hand etc.]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 01.10.2021